Click the images for more information
Honorary Research Associates
Dr Sean D. Galvin
Consultant Cardiothoracic Surgeon
Dr Bronwen Kelly
BSc(Hons) Logopaedics, MSLT, PhD
Health and Clinical Researcher
Dr Philip Leadbitter
MBChB, DCH, FRACP
Paediatrician and Clinical Researcher
Dr Sean Mackay
Chemist and Nanoscale Materials Scientist
Dr Simon McDowell
FRANZCOG, CREI, MBChB, PGDipOMG, MrMED
Consultant Fertility Specialist and Gynaecologist
Dr Eng W Tan
Organic and Bioorganic Chemist and Research Scientist
Dr Agadha Wickremesekera
MBChB, MD, FRACS
Neurosurgeon and Research Scientist
Dr S Kusal Wickremesekera
MBChB, PhD, FRACS
Upper GI, Hepatopancreaticobiliary and Laparoscopic Surgeon and Research Scientist
Our Health Sector Collaborators
Health partnership will progress cancer cure
The GMRI is a signatory to a health partnership that hopes to translate laboratory research into radically improved treatment of diseases, including cancer.
The partnership is a collaboration between the Gillies McIndoe Research Institute and the Wairarapa, Hutt Valley, and Capital & Coast DHBs.
The three DHBs have a formal memorandum of understanding with the GMRI to promote close interchange, collaboration and sharing of ideas between leading DHB clinicians and the GMRI’s scientists.
The partnership creates a closer working relationship between the four organisations and will enhance research opportunities and improve educational, business, health and social outcomes.
As part of signing this MOU, Wairarapa and Hutt Valley DHB Chief Executive, Graham Dyer, noted that the team at the GMRI is internationally recognised for their ground-breaking work.
Interim chief executive, Debbie Chin, said at the time that Capital & Coast DHB was pleased to accommodate the GMRI in a new purpose-built laboratory next to Wellington Hospital.
Capital & Coast and Hutt Valley DHB chair, Dr Virginia Hope, said many highly-regarded international experts and organisations understand the immense potential of the discoveries of Dr Tan’s team, and their implication for the treatment of cancer.
This MOU and the health partnership it underpins enshrines the collaboration and co-operation that has been a feature of Dr Tan’s and the GMRI’s work.